AstraZeneca PLC (AZNCF)
OTCMKTS · Delayed Price · Currency is USD
141.90
+2.20 (1.57%)
Jul 22, 2025, 3:45 PM EDT
AstraZeneca Revenue
AstraZeneca had revenue of $13.59B in the quarter ending March 31, 2025, with 7.17% growth. This brings the company's revenue in the last twelve months to $54.98B, up 15.48% year-over-year. In the year 2024, AstraZeneca had annual revenue of $54.07B with 18.03% growth.
Revenue (ttm)
54.98B
Revenue Growth
+15.48%
P/S Ratio
3.94
Revenue / Employee
583.05K
Employees
94,300
Market Cap
216.82B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
AstraZeneca News
- 15 hours ago - 5 Ideal "Safer" Dividend Buys From Bloomberg's July Watch List - Seeking Alpha
- 15 hours ago - AstraZeneca investing $50B in US, Trump calls it an 'honor' - The Hill
- 16 hours ago - AstraZeneca announces $50 billion investment in U.S. as Trump's tariffs loom - Fast Company
- 20 hours ago - AstraZeneca to invest US$50B in U.S. by 2030 - BNN Bloomberg
- 22 hours ago - 5 Things to Know Before the Stock Market Opens - Investopedia
- 23 hours ago - Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push - The Times of India
- 23 hours ago - AstraZeneca unveils $37 billion US investment plan amid tariff threats - Premium Times Nigeria
- 23 hours ago - AstraZeneca Plans to Invest $50B in US Manufacturing and Research by 2030 - Investopedia